Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CRACR2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CDH2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR8071-2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
UCP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC85B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTTG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPBG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GDF11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LETM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERP29 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPD52 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COX8A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM109 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MEF2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RCN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APBB1IP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HMCES - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRDX5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RHOB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on